Astrazeneca Pharma India Q2 Results 2024: Astrazeneca Pharma India declared its Q2 results for 2024 on November 13, revealing a significant increase in revenue but a decline in profit compared to the previous year. The company’s revenue for the quarter stood at ₹408 crore, reflecting a 31.16% year-over-year growth, while profit decreased by 26.62% year-over-year to ₹38.43 crore.
Open Flip
Ratnamani Metals & Tubes Q2 Results 2024: Ratnamani Metals & Tubes declared its Q2 results for 2024 on 14 Nov, 2024, revealing a significant decline in its financial performance. The company reported a revenue of ₹971.33 crore, representing a 14.13% decrease year-over-year, and a profit of ₹100.39 crore, which is down 38.74% compared to the same quarter last year.
Open Flip
Deepak Nitrite's Q2FY25 revenue rose 14.3% YoY to Rs20.3bn, driven by a 29% increase in Phenolics segment revenue, despite challenges in the Advanced Intermediates business. The company announced Rs50bn capex to produce PC resins, aiming to double phenol capacity over 4 years, but near-term headwinds are expected to continue.
Open Flip
